BCR-ABL1-Associated Reduction of Beta Catenin Antagonist Chibby1 in Chronic Myeloid Leukemia-Reference-Cited by-同舟云学术

BCR-ABL1-Associated Reduction of Beta Catenin Antagonist Chibby1 in Chronic Myeloid Leukemia

Published:2013-12-10 Issue:12 Volume:8 Page:e81425
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Leo Elisa,Mancini Manuela,Aluigi Michela,Luatti Simona,Castagnetti Fausto,Testoni Nicoletta,Soverini Simona,Santucci Maria Alessandra,Martinelli Giovanni

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference49 articles.

1. Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of Philadelphia chromosome;GQ Daley;Science,1990

2. A coiled-coil oligomerization domain of Bcr is essential for transforming function of Bcr-Abl oncoproteins;JR McWhirter;Mol Cell Biol,1993

3. Five year follow-up of patients receiving imatinib for chronic myeloid leukemia;F Druker;N Engl J Med,2006

4. Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for survival;A Hamilton;Blood,2012

5. Loss of beta catenin impairs the renewal of normal and CML stem cells in vivo;C Zhao;Cancer Cell,2007

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of Resistance and Implications for Treatment Strategies in Chronic Myeloid Leukaemia;Cancers;2022-07-06

2. Combined Inhibition of Polo-Like Kinase-1 and Wee1 as a New Therapeutic Strategy to Induce Apoptotic Cell Death in Neoplastic Mast Cells;Cancers;2022-01-31

3. Benzene and its effects on cell signaling pathways related to hematopoiesis and leukemia;Journal of Applied Toxicology;2020-02-28

4. Leukemia stem cell immunophenotyping tool for diagnostic, prognosis, and therapeutics;Journal of Cellular Physiology;2019-11-10

5. Overcoming Tyrosine Kinase Inhibitor Resistance in Transformed Cell Harboring SEPT9-ABL1 Chimeric Fusion Protein;Neoplasia;2019-08